Moting Liu

机构：University Medical Center Groningen, University of Groningen · ORCID：0000-0002-9745-9752

发表论文 15 篇 · 总被引 295 次 · h-index 8

代表论文

• Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases (2024 · Gut · 被引 92)
• Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis (2021 · Acta Pharmaceutica Sinica B · 被引 48)
• Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis (2024 · Inflammatory Bowel Diseases · 被引 35)
• Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis (2021 · Cellular Immunology · 被引 35)
• Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation (2021 · Journal of Advanced Research · 被引 24)
• Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages (2025 · FEBS Journal · 被引 18)